(October 3, 2017, 1:38 PM EDT) -- WASHINGTON, D.C. — A Texas federal judge’s decision to vacate a jury’s finding of patent infringement with regard to the “Express” coronary stent was affirmed by the Federal Circuit U.S. Court of Appeals on Sept. 29 (G. David Jang, M.D. v. Boston Scientific Corp., et al., No. 16-1275, Fed. Cir., 2017 U.S. App. LEXIS 18825)....